UHLMANN PRICE SECURITIES’s AbbVie ABBV Stock Holding History

UHLMANN PRICE SECURITIES’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.17M	Sell	12,593 -282	-2%	-$60.7K	0.12%	20
2026 Q1	$2.71M	Buy	12,875 +7,523	+141%	+$1.67M	0.18%	22
2025 Q4	$1.22M	Buy	5,352 +19	+0.4%	+$4.33K	0.73%	34
2025 Q3	$1.23M	Buy	5,333 +203	+4%	+$41.3K	0.75%	33
2025 Q2	$952K	Buy	5,130 +116	+2%	+$21.6K	0.68%	36
2025 Q1	$1.05M	Sell	5,014 -13	-0.3%	-$2.53K	0.77%	32
2024 Q4	$893K	Buy	5,027 +27	+0.5%	+$4.96K	0.67%	36
2024 Q3	$987K	Buy	+5,000	New	+$933K	0.78%	29

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UHLMANN PRICE SECURITIES's ABBV Position: Q2 2026 in Review

UHLMANN PRICE SECURITIES reduced its AbbVie (ABBV) stake by 2.2% in Q2 2026, selling an estimated $60.7K and leaving 12,593 shares worth $3.17M. The position accounts for 0.12% of the portfolio, ranked #20.

UHLMANN PRICE SECURITIES first reported a position in ABBV in Q3 2024 and has held it in 8 quarters since. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

UHLMANN PRICE SECURITIES held 12,593 shares of AbbVie worth $3.17M as of Q2 2026.
UHLMANN PRICE SECURITIES sold 282 AbbVie shares in Q2 2026, an estimated $60.7K.
AbbVie made up 0.12% of UHLMANN PRICE SECURITIES's portfolio in Q2 2026, its #20 holding.
UHLMANN PRICE SECURITIES first reported a position in AbbVie in Q3 2024 and has held it in 8 quarters since.
4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on UHLMANN PRICE SECURITIES's 13F filing for Q2 2026, filed 24 Jul 2026.